TREM2 marks tumor-associated macrophages

por Nakamura, Kyohei, Smyth, Mark J.
Publicado 2020

NKT cell adjuvants in therapeutic vaccines against hematological cancers

por Mattarollo, Stephen R., Smyth, Mark J.
Publicado 2013

2018 Nobel Prize in physiology or medicine

por Smyth, Mark J, Teng, Michele WL
Publicado 2018

Targeting the IL-12/IL-23 axis: An alternative approach to removing tumor induced immune suppression

por Smyth, Mark J, Teng, Michele W L
Publicado 2014

Targeting immune checkpoints in hematological malignancies

por Salik, Basit, Smyth, Mark J., Nakamura, Kyohei
Publicado 2020

DNAM-1: would the real natural killer cell please stand up!

por Huntington, Nicholas D., Martinet, Ludovic, Smyth, Mark J.
Publicado 2015

A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas

por Crowe, Nadine Y., Smyth, Mark J., Godfrey, Dale I.
Publicado 2002

Hypoxia-driven immunosuppression contributes to the pre-metastatic niche

por Sceneay, Jaclyn, Parker, Belinda S., Smyth, Mark J., Möller, Andreas
Publicado 2013

The anticancer effects of HDAC inhibitors require the immune system

por West, Alison C, Smyth, Mark J, Johnstone, Ricky W
Publicado 2014

IFN type III: in vivo NK cell response

por Souza-Fonseca-Guimaraes, Fernando, Young, Arabella, Smyth, Mark J.
Publicado 2015

Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity

por Dougall, William C., Roman Aguilera, Amelia, Smyth, Mark J.
Publicado 2019

Interleukin 2 Receptor Signaling Regulates the Perforin Gene through Signal Transducer and Activator of Transcription (Stat)5 Activation of Two Enhancers

por Zhang, Jin, Scordi, Irinoulla, Smyth, Mark J., Lichtenheld, Mathias G.
Publicado 1999

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?

por O’Donnell, Jake S., Smyth, Mark J., Teng, Michele W. L.
Publicado 2016

PD1 functions by inhibiting CD28-mediated co-stimulation

por O'Donnell, Jake S, Smyth, Mark J, Teng, Michele W L
Publicado 2017

Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies

por Liu, Jing, Blake, Stephen J, Smyth, Mark J, Teng, Michele WL
Publicado 2014

The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects

por West, Alison C., Christiansen, Ailsa J., Smyth, Mark J., Johnstone, Ricky W.
Publicado 2012

Non-classical MHC Class I molecules regulating natural killer cell function

por Smyth, Mark J., Sullivan, Lucy C., Brooks, Andrew G., Andrews, Daniel M.
Publicado 2013

Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ

por Street, Shayna E.A., Trapani, Joseph A., MacGregor, Duncan, Smyth, Mark J.
Publicado 2002

Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodies

por Verbrugge, Inge, Galli, Mara, Smyth, Mark J., Johnstone, Ricky W., Haynes, Nicole M.
Publicado 2012

A(2A) blockade enhances anti-metastatic immune responses

por Beavis, Paul A, Milenkovski, Nicole, Stagg, John, Smyth, Mark J, Darcy, Phillip K
Publicado 2013